Rebecca Luckett1, Neo Mogowa, Howard J Li, Adrienne Erlinger, Michele R Hacker, Katharine Esselen, Sarah Feldman, Roger Shapiro, Chelsea Morroni, Doreen Ramogola-Masire. 1. Botswana Harvard AIDS Initiative Partnership, Gaborone, Botswana; the Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; the Department of Obstetrics and Gynaecology, University of Botswana, Gaborone, Botswana; Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Brigham and Women's Hospital, Boston, Massachusetts; the Department of International Public Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; and the Botswana UPenn Partnership, Gaborone, Botswana.
Abstract
OBJECTIVE: To evaluate the performance of cervical cancer screening algorithms for women living with human immunodeficiency virus (HIV), using primary high-risk human papillomavirus (HPV) testing followed by cytology, visual inspection with acetic acid, or colposcopy. METHODS: We conducted a prospective cohort study of women living with HIV in Botswana. All participants underwent high-risk HPV testing. Participants with positive high-risk HPV test results underwent cytology, visual inspection with acetic acid, colposcopy, and biopsy. Participants with negative high-risk HPV test results also underwent cytology. Histopathology was the reference standard for determination of preinvasive cervical disease and cervical cancer. Sensitivity, specificity, positive predictive value (PPV), negative predictive value, and likelihood ratios (LR) of high-risk HPV-based two-stage screening algorithms were calculated. RESULTS: Among 300 women screened, 88 (29%) had a positive high-risk HPV test result, and 29 of the 88 (35%) women who tested positive for high-risk HPV had CIN 2 or higher on histopathology. High-risk HPV followed by colposcopy resulted in a sensitivity of 83%, specificity of 49%, PPV of 47%, LR+ of +1.6, and LR- of -0.4. High-risk HPV followed by visual inspection with acetic acid resulted in a reduced sensitivity of 59%, specificity of 49%, PPV of 39%, LR+ of +1.2, and LR- of -0.8. High-risk HPV testing followed by cytology also resulted in a reduced sensitivity of 62%, specificity of 77%, PPV of 60%, LR+ of +2.7, and LR- of -0.5. Stratification by HPV 16/18/45 did not improve performance of the algorithms. CONCLUSION: In a high-risk population with HIV, high-risk HPV testing followed by colposcopy demonstrated the highest sensitivity and PPV in detecting high-grade cervical dysplasia. Allocating resources to colposcopy in resource-limited settings may be more effective than other screening strategies.
OBJECTIVE: To evaluate the performance of cervical cancer screening algorithms for women living with human immunodeficiency virus (HIV), using primary high-risk human papillomavirus (HPV) testing followed by cytology, visual inspection with acetic acid, or colposcopy. METHODS: We conducted a prospective cohort study of women living with HIV in Botswana. All participants underwent high-risk HPV testing. Participants with positive high-risk HPV test results underwent cytology, visual inspection with acetic acid, colposcopy, and biopsy. Participants with negative high-risk HPV test results also underwent cytology. Histopathology was the reference standard for determination of preinvasive cervical disease and cervical cancer. Sensitivity, specificity, positive predictive value (PPV), negative predictive value, and likelihood ratios (LR) of high-risk HPV-based two-stage screening algorithms were calculated. RESULTS: Among 300 women screened, 88 (29%) had a positive high-risk HPV test result, and 29 of the 88 (35%) women who tested positive for high-risk HPV had CIN 2 or higher on histopathology. High-risk HPV followed by colposcopy resulted in a sensitivity of 83%, specificity of 49%, PPV of 47%, LR+ of +1.6, and LR- of -0.4. High-risk HPV followed by visual inspection with acetic acid resulted in a reduced sensitivity of 59%, specificity of 49%, PPV of 39%, LR+ of +1.2, and LR- of -0.8. High-risk HPV testing followed by cytology also resulted in a reduced sensitivity of 62%, specificity of 77%, PPV of 60%, LR+ of +2.7, and LR- of -0.5. Stratification by HPV 16/18/45 did not improve performance of the algorithms. CONCLUSION: In a high-risk population with HIV, high-risk HPV testing followed by colposcopy demonstrated the highest sensitivity and PPV in detecting high-grade cervical dysplasia. Allocating resources to colposcopy in resource-limited settings may be more effective than other screening strategies.
Authors: Jennifer S Smith; Lisa Lindsay; Brooke Hoots; Jessica Keys; Silvia Franceschi; Rachel Winer; Gary M Clifford Journal: Int J Cancer Date: 2007-08-01 Impact factor: 7.396
Authors: Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz Journal: JAMA Date: 2007-02-28 Impact factor: 56.272
Authors: Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2015-02-04 Impact factor: 508.702
Authors: Lynette A Denny; Silvia Franceschi; Silvia de Sanjosé; Isabelle Heard; Anna Barbara Moscicki; Joel Palefsky Journal: Vaccine Date: 2012-11-20 Impact factor: 3.641
Authors: Nancy Santesso; Reem A Mustafa; Holger J Schünemann; Marc Arbyn; Paul D Blumenthal; Joanna Cain; Michael Chirenje; Lynette Denny; Hugo De Vuyst; Linda O'Neal Eckert; Sara E Forhan; Eduardo L Franco; Julia C Gage; Francisco Garcia; Rolando Herrero; José Jeronimo; Enriquito R Lu; Silvana Luciani; Swee Chong Quek; Rengaswamy Sankaranarayanan; Vivien Tsu; Nathalie Broutet Journal: Int J Gynaecol Obstet Date: 2015-12-14 Impact factor: 3.561
Authors: Philip E Castle; John E Varallo; Margaret Mary Bertram; Bakgaki Ratshaa; Moses Kitheka; Kereng Rammipi Journal: PLoS One Date: 2020-02-13 Impact factor: 3.240
Authors: Helen A Kelly; Admire Chikandiwa; Bernard Sawadogo; Clare Gilham; Pamela Michelow; Olga Goumbri Lompo; Tanvier Omar; Souleymane Zan; Precious Magooa; Michel Segondy; Nicolas Nagot; Nicolas Meda; Sinead Delany-Moretlwe; Philippe Mayaud Journal: PLoS Med Date: 2021-03-04 Impact factor: 11.069
Authors: Helen Kelly; Iman Jaafar; Michael Chung; Pamela Michelow; Sharon Greene; Howard Strickler; Xianhong Xie; Mark Schiffman; Nathalie Broutet; Philippe Mayaud; Shona Dalal; Marc Arbyn; Silvia de Sanjosé Journal: EClinicalMedicine Date: 2022-09-27